KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Cash from Operations (2016 - 2025)

Fulgent Genetics' Cash from Operations history spans 10 years, with the latest figure at 78143000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations fell 412.35% year-over-year to 78143000.0; the TTM value through Dec 2025 reached 101638000.0, down 582.61%, while the annual FY2025 figure was 101638000.0, 582.61% down from the prior year.
  • Cash from Operations for Q4 2025 was 78143000.0 at Fulgent Genetics, down from 11107000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 233179000.0 in Q1 2021 and bottomed at 78143000.0 in Q4 2025.
  • The 5-year median for Cash from Operations is 11116500.0 (2022), against an average of 36926100.0.
  • The largest annual shift saw Cash from Operations skyrocketed 16970.2% in 2021 before it tumbled 804.11% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 77086000.0 in 2021, then tumbled by 56.92% to 33207000.0 in 2022, then crashed by 55.03% to 14933000.0 in 2023, then soared by 67.53% to 25018000.0 in 2024, then plummeted by 412.35% to 78143000.0 in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Cash from Operations are 78143000.0 (Q4 2025), 11107000.0 (Q3 2025), and 30171000.0 (Q2 2025).